Quanta Dialysis Technologies - About the company
Quanta Dialysis Technologies is a series E company based in Warwick (United Kingdom), founded in 2008 by John Milad. It operates as a Provider of a dialysis system offering multiple kidney therapy modalities. Quanta Dialysis Technologies has raised $433M in funding from investors like Wellington Partners Venture Capital, Air Liquide and Novo Holdings, with a current valuation of $*****. The company has 33 active competitors, including 8 funded and 6 that have exited. Its top competitors include companies like Outset Medical, Diality and Renalyx.
Company Details
Provider of a dialysis system offering multiple kidney therapy modalities. The company offers Dialysis System to provide multiple hemodialysis modalities on a single, convenient platform without the need for traditional bags. This versatility allows healthcare providers to utilize the same system for different clinical requirements.
- Website
- quantadt.com
- Email ID
- *****@quantadt.com
- Registered Address
- Tything Road, Alcester, Warwickshire, B49 6EU
Key Metrics
Founded Year
2008
Location
Warwick, United Kingdom
Stage
Series E
Total Funding
$433M in 9 rounds
Latest Funding Round
Post Money Valuation
$***** as on Jun 19, 2017
Investors
Ranked
2nd among 33 active competitors
Annual Revenue
£0 - £1M as on Dec 31, 2024
Employee Count
134 as on Aug 31, 2026
Similar Companies
Legal entities associated with Quanta Dialysis Technologies
Quanta Dialysis Technologies is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
QUANTA DIALYSIS TECHNOLOGIES LIMITED CIN: 6641134 , Germany, Active | Jul 07, 2008 | £0 - £1M (As on Dec 31, 2024) | 183 (As on Dec 31, 2024) |
Sign up to download Quanta Dialysis Technologies' company profile
Quanta Dialysis Technologies's funding and investors
Quanta Dialysis Technologies has raised a total funding of $433M over 9 rounds. Its first funding round was on Sep 17, 2009. Its latest funding round was a Series E round on Nov 18, 2024 for $*****. 3 investors participated in its latest round. Quanta Dialysis Technologies has 30 institutional investors and 2 angel investors.
Here is the list of recent funding rounds of Quanta Dialysis Technologies:
Filter this list
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Nov 18, 2024 | 7838193 | Series E | 4331211 | 8675719 | 5431959 | 7552526 |
Jun 23, 2021 | 9340910 | Series D | 9358513 | 8695427 | 3753653 | |
Jul 29, 2019 | 5516574 | Series C | 6233432 | 1994037 |
View details of Quanta Dialysis Technologies's funding rounds and investors
Quanta Dialysis Technologies' founders and board of directors
Founder? Claim ProfileThe founders of Quanta Dialysis Technologies is John Milad. Alejandro Galindo is the CEO of Quanta Dialysis Technologies.
Here are the details of Quanta Dialysis Technologies' key team members:
- John Milad: Former Co-Founder of Quanta Dialysis Technologies.
- Alejandro Galindo: CEO of Quanta Dialysis Technologies.
Quanta Dialysis Technologies' Board of Directors
Quanta Dialysis Technologies's board has 9 active members. Rainer Strohmenger and Alejandro Galindo are part of team and Leslie Victoria Norwalk, Johan Lourens De Ruiter, Daniel O'mahoney, Christian Schuetz, Hooman Hakami, Hongjie Hu and Lloyd Mandell are independent board members.Here is the list of Quanta Dialysis Technologies' board of directors:
Name | Type | Representing | Status | Duration |
|---|---|---|---|---|
dluibyz | Team | - | Current | 9y 6m |
Investor | - | Current | 16y 9m | |
Independent board member | - | Current | 4y 7m | |
{bqxnoo | Independent board member | - | Current | 2y 4m |
cvjujpu | Independent board member | - | Current | 7y 7m |
odyunmw | Independent board member | - | Current | 5y 4m |
o{kzudc | Independent board member | - | Current | 8y 9m |
umsjsnu | Independent board member | - | Current | 2y 5m |
yjnffkx | Independent board member | - | Current | 9y 8m |
Quanta Dialysis Technologies' employee count trend
Quanta Dialysis Technologies has 134 employees as of Aug 26. Here is Quanta Dialysis Technologies's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Quanta Dialysis Technologies's Competitors and alternates
Top competitors of Quanta Dialysis Technologies include Outset Medical, Diality and Renalyx. Here is the list of Top 10 competitors of Quanta Dialysis Technologies, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Outset Medical 2003, San Jose (United States), Public | Provider of hemodialysis machine with touchscreen display | $458M | 64/100 | |
2nd | Quanta Dialysis Technologies 2008, Warwick (United Kingdom), Series E | Provider of a dialysis system offering multiple kidney therapy modalities | $433M | 50/100 | |
3rd | Diality 2013, Irvine (United States), Series C | Developer of portable hemodialysis device | $82.5M | - | 55/100 |
4th | Developer of renal care solutions including dialysis and CKD detection | $1.25M | 55/100 | ||
5th | Manufacturer of a hemodialysis monitoring device | $15.9M | 53/100 | ||
6th | NxStage 1998, Lawrence (United States), Acquired | Home dialysis therapies and systems for kidney disease patients | - | 39/100 | |
7th | Manufacturer of renal care products | $4M | 37/100 | ||
8th | NovaFlux Technologies 1988, Princeton (United States), Funding Raised | Innovating healthcare through advanced medical device technologies and infection control | - | 33/100 | |
9th | Hemosphere 1998, Kennesaw (United States), Acquired | Hemodialysis access solutions improving patient outcomes and reducing catheter dependency | $9.3M | 33/100 | |
10th | Therapies for kidney and liver dialysis, myeloma therapy, and extracorporeal therapies for both chronic and acute patients | - | - | 33/100 |
Looking for more details on Quanta Dialysis Technologies's competitors? Click here to see the top ones
Quanta Dialysis Technologies's Investments and acquisitions
Quanta Dialysis Technologies has made no investments or acquisitions yet.
Reports related to Quanta Dialysis Technologies
Here is the latest report on Quanta Dialysis Technologies's geography:
News related to Quanta Dialysis Technologies
Media has covered Quanta Dialysis Technologies for 1 event in last 1 year, It was about company updates.
•
•
•
Quanta™ Dialysis System Receives FDA Clearance for Home HemodialysisQuanta Dialysis Technologies•Nov 04, 2024•Quanta Dialysis Technologies
•
•
Quanta™ Appoints Suresh Persaud Senior Director of Global Manufacturing and OperationsQuanta Dialysis Technologies•Aug 08, 2023•Quanta Dialysis Technologies
•
•
Quanta™ Receives FDA 510(k) Clearance for Expanded Indication of Continuous Renal Replacement TherapiesQuanta Dialysis Technologies•Aug 03, 2023•Quanta Dialysis Technologies
•
Bodyport Appoints John Lipman as Chief Executive OfficerBusiness Wire•Jun 15, 2022•Bodyport, Quanta Dialysis Technologies
•
Meghan Fitzgerald, Leslie Norwalk Join Quanta Dialysis BoardMedical Product Outsourcing•Mar 16, 2022•Quanta Dialysis Technologies, LetterOne
•
QUANTA Dialysis Technologies Appoints Meghan Fitzgerald and Leslie Norwalk to Board of DirectorsBusiness Wire•Jan 10, 2022•Quanta Dialysis Technologies, LetterOne, Goldman Sachs, Epstein Becker Green and 1 other
Are you a Founder ?
FAQs about Quanta Dialysis Technologies
Explore our recently published companies
- Elm Biosciences - New York City based, 2024 founded, Seed company
- Whoranks - Wien based, 2024 founded, Funding Raised company
- Hedlum - New York City based, 2023 founded, Funding Raised company
- Granted Health - New York City based, 2023 founded, Funding Raised company
- XO Semiconductor - Chuncheon based, 2024 founded, Funding Raised company
- FloWorks - 2011 founded, Seed company
